financial disclosure

35
I have the following financial interests or relationships to disclose: OMIC-Ophthalmic Mutual Insurance Company - C,L, Santen, Inc. - C, Financial Disclosure

Upload: zudora

Post on 12-Feb-2016

50 views

Category:

Documents


2 download

DESCRIPTION

Financial Disclosure. I have the following financial interests or relationships to disclose: OMIC-Ophthalmic Mutual Insurance Company - C,L, Santen, Inc. - C,. PROMOTING AND IMPLEMENTING CLINICAL PRACTICE GUIDELINES IN DEVELOPING COUNTRIES: THE CHINA EXPERIENCE. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Financial Disclosure

I have the following financial interests or relationships to disclose:– OMIC-Ophthalmic Mutual Insurance

Company - C,L,– Santen, Inc. - C,

Financial Disclosure

Page 2: Financial Disclosure

PROMOTING AND IMPLEMENTING CLINICAL PRACTICE GUIDELINES IN DEVELOPING COUNTRIES:

THE CHINA EXPERIENCE

ACADEMIA OPHTHALMOLOGICA INTERNATIONALISINAUGURAL LECTURE

OCTOBER 24, 2009SAN FRANCISCO

Page 3: Financial Disclosure

RICHARD L. ABBOTT, M.DTHOMAS W. BOYDEN HEALTH SCIENCES PROFESSOR OF OPHTHALMOLOGY

UNIVERSITY OF CALIFORNIA SAN FRANCISCO

SENIOR ADVISOR FOR INTERNATIONAL EDUCATIONAMERICAN ACADEMY OF OPHTHALMOLOGY

CHAIRMAN CLINICAL GUIDELINES COMMITTEE

INTERNATIONAL COUNCIL OF OPHTHALMOLOGY

Page 4: Financial Disclosure

DOES ONE SIZE FIT ALL?

WHAT HAVE WE LEARNED FROM CHINA AND CAN IT BE APPLIED TO

OTHER COUNTRIES?

Page 5: Financial Disclosure

CLINICAL PRACTICE GUIDELINES

PROJECT IN CHINACOLLABORATIVE EFFORT

BETWEEN:

COS

Page 6: Financial Disclosure

CLINICAL PRACTICE GUIDELINES PROJECT IN

CHINADEVELOPMENT PHASE

(2004-2006)

Page 7: Financial Disclosure

CLINICAL PRACTICE GUIDELINES PROJECT IN

CHINA Development Promotion

– Awareness– Agreement– Adoption– Compliance

FOUR STEPS

Page 8: Financial Disclosure

PROMOTION OF CLINICAL PRACTICE GUIDELINES IN

CHINA

BEIJING 2006

Page 9: Financial Disclosure

AWARENESS

Must know that they exist

Must be familiar with concept

Must have educational programs

Page 10: Financial Disclosure

WHAT HAVE WE LEARNED FROM CHINA AND HOW CAN IT BE APPLIED TO OTHER COUNTRIES?

Page 11: Financial Disclosure

PROCESS FOR IMPLEMENTATION

Work through governmental, national and local societies

Create a “steering committee” of interested and influential leaders

Page 13: Financial Disclosure

KEY PRINCIPLES

LOCAL LEADERSHIP AND STRONG DESIRE TO IMPROVE QUALITY OF CARE (ZEALOT(S)!)

NEED FUNDING TO SUPPORT WORK

STRUCTURE OR ROAD MAP ON STEPS REQUIRED TO SUCCEED

INCENTIVES TO FOLLOW GUIDELINES

Page 14: Financial Disclosure

HOW ARE GUIDELINES BEST INCORPORATED INTO CLINICAL

PRACTICE? Create awareness through:

– Wide dissemination– Education process

(meetings, journals, internet)

– 14th COS Congress in Chongqing had entire day of seminars

Page 15: Financial Disclosure

Physician compliance with guideline use

is significant challenge

Page 16: Financial Disclosure

COMPLIANCE Ease of incorporation into

practice

Minimal change required by physician

Minimal cost

Little time constraints

Page 17: Financial Disclosure

COMPLIANCE

Need Incentives (or Penalties)– Bonus– Lower costs– More patients– Recognition

– Lower re-imbursement– Loss of licensure

Page 18: Financial Disclosure

GOVERNMENT SUPPORT

MINISTRY OF HEALTH RECOGNITION (April, 2009)!

Page 19: Financial Disclosure

STUDIES IN CHINA TO EXAMINE AWARENESS OF PPPs AND

BARRIERS TO USE (COMPLIANCE)

EYE CENTER OF PEOPLES HOSPITAL-PEKING UNIVERSITY– Professor Li Xiaoxin

TONGREN HOSPITAL – BEIJING– Professor Wang Ningli

Page 20: Financial Disclosure

20

美国眼科临床指南的适用性研究 Assessment of Ophthalmological Care Before and

After the Introduction of Clinical Practice Guidelines in 3rd level Hospitals in Beijing ——青光眼部分 (Glaucoma section)北京同仁眼科中心

Beijing Tongren Eye Center王宁利Ningli Wang

Page 21: Financial Disclosure

Question 1:

Why do we have to implement CLINICAL PRACTICE GUIDELINES

in China?

21

Page 22: Financial Disclosure

22

Answer:

Lack of consistent quality and evidence based diagnosis and treatment in China.

Page 23: Financial Disclosure

Tongren survey result:

Most of the doctors in 3rd level hospital know about clinical guideline content.

But few doctors completely follow recommendations in their clinical work.

23

Page 24: Financial Disclosure

TONGREN HOSPITAL SURVEY RESULTS

GLAUCOMA (TONGREN VS PROVINCIAL HOSPITAL)

– ONH EVALUATION FOR GLAUCOMA PT? TONGREN: 100% PROVINCIAL: 35%

– INQUIRE ABOUT SYSTEMIC MECICAL HX? TONGREN:98% PROVINCIAL: 77%

– TARGET PRESSURE FOR EACH PT? TONGREN: 52% PROVINCIAL: 6%

– RECORD TIME OF IOP MEASURMENT? TONGREN: 44% PROVINCIAL: 14%

Page 25: Financial Disclosure

25

Question 2:

Why have Clinical Guidelines not been implemented in

China?

Page 26: Financial Disclosure

26

Answer:

Current practice pattern of diagnosis & management in China difficult to meet

requirements of clinical guideline

Page 27: Financial Disclosure

EXAMPLE OF CLINICAL GUIDELINE FOR ANGLE CLOSURE GLAUCOMA

Gonioscopy [A: ]Ⅲ

Documentation of the optic disc morphology, best performed by color stereophotography or computer based image analysis [A: ]Ⅱ

Visual field evaluation [A: ]Ⅲ

topical medications constitute effective initial therapy [A: ]Ⅲ

27

Page 28: Financial Disclosure

28

Gonioscopy • lens often not available• time-consuming• no re-imbursement

optic disc morphology• no computer based image analysis center• time-consuming • no re-imbursement

Visual field • lack of equipment• waiting period too long• many patients lost to follow-up

topical medications• no or limited education for patients• poor compliance

Example:

Page 29: Financial Disclosure

29

Question 3:

How do we implement clinical guidelines in China?

Require Administrative intervention?

Page 30: Financial Disclosure

30

Answer: Its not easy!

High volume of patients would require more to be done for each

patient!

Doctors’ work load would be increased

Page 31: Financial Disclosure

31

Question 4:

What can we do now?

Page 32: Financial Disclosure

32

Answer:

Set up a simple, convenient and efficient diagnosis &

management system that can integrate with clinical

guidelines

Page 33: Financial Disclosure

Modify current medical record format according to PPP

33

EX: Gonioscopy Descriptive

Static:

OD OS

Pigment trabecular 0: No-see. ( Label in quadrant area.) 1: see

Dynamic: Delineate PAS extent and degree by line.

OD│_│ 个钟点 OD│_│ 个钟点

Page 34: Financial Disclosure

FAILURE TO IMPLEMENT GUIDELINES

NOT CREDIBLE TO PRACTITIONER

TOO COMPLEX

REQUIRES RESOURCES THAT ARE NOT READILY AVAILABLE

RADICALLY DIFFERENT FROM PREVAILING TREATMENT NORM

Page 35: Financial Disclosure

THANK YOU!!THANK YOU!!